Literature DB >> 28600980

Structural insights into ligand recognition and regulation of nucleic acid-sensing Toll-like receptors.

Toshiyuki Shimizu1.   

Abstract

Toll-like receptors (TLRs) activate the innate immune system in response to invading pathogens. Although nucleic acids are one of the principal TLR ligands, they are not inherently pathogen-specific and, thus, carry the risk of triggering autoimmunity. There are multiple unique regulatory mechanisms aimed at preventing accidental activation of nucleic acid-sensing TLRs. Recent structural studies revealed that different nucleic acid-sensing TLRs have specific modes of recognizing nucleic acids as ligands regulated by diverse regulation mechanism both at the receptor and ligand levels. This review summarizes structural knowledge on the ligand recognition and regulation mechanism by nucleic acid-sensing TLRs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2017        PMID: 28600980     DOI: 10.1016/j.sbi.2017.05.010

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  12 in total

Review 1.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 2.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Authors:  Mélanie Souyris; José E Mejía; Julie Chaumeil; Jean-Charles Guéry
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 3.  Structural and functional understanding of the toll-like receptors.

Authors:  Jinta Asami; Toshiyuki Shimizu
Journal:  Protein Sci       Date:  2021-02-24       Impact factor: 6.725

4.  Inhibitory Effects of Dietary N-Glycans From Bovine Lactoferrin on Toll-Like Receptor 8; Comparing Efficacy With Chloroquine.

Authors:  Susana Figueroa-Lozano; Rivca L Valk-Weeber; Renate Akkerman; Wayel Abdulahad; Sander S van Leeuwen; Lubbert Dijkhuizen; Paul de Vos
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

Review 5.  Cytokine Targeting by miRNAs in Autoimmune Diseases.

Authors:  Valentina Salvi; Veronica Gianello; Laura Tiberio; Silvano Sozzani; Daniela Bosisio
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 6.  Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.

Authors:  Chao-Yang Lai; Guann-Yi Yu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

7.  A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.

Authors:  Hidenori Ando; Masakazu Fukushima; Kiyoshi Eshima; Taichi Hasui; Taro Shimizu; Yu Ishima; Cheng-Long Huang; Hiromi Wada; Tatsuhiro Ishida
Journal:  Cancer Med       Date:  2019-10-14       Impact factor: 4.452

8.  Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  mSystems       Date:  2021-06-29       Impact factor: 6.496

9.  Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.

Authors:  Yun-Fen Hung; Chiung-Ya Chen; Yi-Chun Shih; Hsin-Yu Liu; Chiao-Ming Huang; Yi-Ping Hsueh
Journal:  J Cell Biol       Date:  2018-05-18       Impact factor: 10.539

Review 10.  Pattern recognition receptors in health and diseases.

Authors:  Danyang Li; Minghua Wu
Journal:  Signal Transduct Target Ther       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.